Article Text

Download PDFPDF
Dopamine agonist withdrawal syndrome (DAWS) in a patient with a microprolactinoma

Statistics from


  • Contributors All the authors have seen and agreed with the contents; no other contributors are present. Each author has given: substantial contributions to conception and design, acquisition of data, analysis and interpretation of data; contribution in drafting the article and final approval of the version to be published.

  • Competing interests None.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.